MA31364B1 - Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation - Google Patents
Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisationInfo
- Publication number
- MA31364B1 MA31364B1 MA32329A MA32329A MA31364B1 MA 31364 B1 MA31364 B1 MA 31364B1 MA 32329 A MA32329 A MA 32329A MA 32329 A MA32329 A MA 32329A MA 31364 B1 MA31364 B1 MA 31364B1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation process
- pharmacological composition
- aliphatic chain
- activity
- substituted sulfamide
- Prior art date
Links
- 239000008196 pharmacological composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 title 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- FWTIELKMNFYUEN-UHFFFAOYSA-N 2-sulfamoylbenzenesulfonyl chloride Chemical compound NS(=O)(=O)C1=CC=CC=C1S(Cl)(=O)=O FWTIELKMNFYUEN-UHFFFAOYSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000001384 anti-glaucoma Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000007344 nucleophilic reaction Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne des sulfamides substitués de formule générale (i) et leurs sels, hydrates et solvates, où r1 représente co ou so2 et r2 nh ou o et où r représente une chaîne aliphatique linéaire ou cyclique et n le nombre d'atomes de carbone de liaison de la chaîne aliphatique (n pouvant être égal à 0, 1, 2 ou 3), utilisables dans la fabrication de médicaments du fait de leur activité en matière d'inhibition de la carboanhydrase. Ces composés sont préparés par une réaction nucléophile entre une amine et du chlorure de sulfamoylbenzènesulfonyle en présence d'un excès de triéthylamine dans du tétrahydrofurane ou de l'éther à une température de 0 à 20 °c. Ces composés présentent une activité anti-glaucome.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SK54-2007A SK542007A3 (sk) | 2007-04-20 | 2007-04-20 | Substituované sulfónamidy, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie |
| PCT/SK2008/050005 WO2008130332A1 (fr) | 2007-04-20 | 2008-04-18 | Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA31364B1 true MA31364B1 (fr) | 2010-05-03 |
Family
ID=39671772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA32329A MA31364B1 (fr) | 2007-04-20 | 2009-11-05 | Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US8193184B2 (fr) |
| EP (1) | EP2142499B1 (fr) |
| JP (1) | JP5492764B2 (fr) |
| CN (1) | CN101663267A (fr) |
| AR (1) | AR065966A1 (fr) |
| AU (1) | AU2008241590B2 (fr) |
| BR (1) | BRPI0809728A2 (fr) |
| CA (1) | CA2684591C (fr) |
| CL (1) | CL2008001109A1 (fr) |
| DK (1) | DK2142499T3 (fr) |
| ES (1) | ES2528284T3 (fr) |
| HR (1) | HRP20141246T1 (fr) |
| HU (1) | HUE024552T2 (fr) |
| IL (1) | IL200952A0 (fr) |
| JO (1) | JO3206B1 (fr) |
| MA (1) | MA31364B1 (fr) |
| MX (1) | MX2009010528A (fr) |
| NZ (1) | NZ581302A (fr) |
| PE (1) | PE20090807A1 (fr) |
| PL (1) | PL2142499T3 (fr) |
| PT (1) | PT2142499E (fr) |
| RU (1) | RU2474574C2 (fr) |
| SA (1) | SA08290238B1 (fr) |
| SI (1) | SI2142499T1 (fr) |
| SK (1) | SK542007A3 (fr) |
| TN (1) | TN2009000421A1 (fr) |
| TW (1) | TWI392492B (fr) |
| UA (1) | UA99279C2 (fr) |
| UY (1) | UY31028A1 (fr) |
| WO (1) | WO2008130332A1 (fr) |
| ZA (1) | ZA200906305B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115141128B (zh) * | 2022-06-24 | 2024-09-13 | 沈阳药科大学 | 3-芳基-3-(磺胺苯甲酰胺基)丙(烯)酸衍生物及其制备方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789938A (en) * | 1952-11-24 | 1957-04-23 | Merck & Co Inc | Method of producing a diuretic effect with p-carboxybenzenesulfonamide |
| CH451142A (de) * | 1965-01-19 | 1968-05-15 | Sandoz Ag | Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide |
| GB1523631A (en) * | 1975-07-08 | 1978-09-06 | Leo Pharm Prod Ltd | Sulphonamide derivatives |
| EP0029090A3 (fr) * | 1979-09-28 | 1981-07-01 | American Cyanamid Company | Sulfonamides contenant un phénol stériquement empêché; composition stabilisée à base d'un polymère synthétique et des sulfonamides mentionnés |
| FR2504528A1 (fr) * | 1981-04-23 | 1982-10-29 | Choay Sa | Dialcoxy (2,4) benzenesulfonamides n-substitues |
| JPS5939867A (ja) * | 1982-08-27 | 1984-03-05 | Fuji Yakuhin Kogyo Kk | ２−クロロスルホニル−４−ｎ−置換スルフアミル−クロロベンゼンの製造法 |
| JPS6041071B2 (ja) * | 1983-07-28 | 1985-09-13 | ソシエテ・デチユ−デ・シヤンテイフイツク・エ・アンデユストリエル・ドウ・リル−ドウ−フランス | 安息香酸誘導体 |
| US4678855A (en) * | 1985-10-09 | 1987-07-07 | Merck & Co., Inc. | Substituted benzenesulfonamides |
| US4721809A (en) * | 1986-09-18 | 1988-01-26 | American Home Products Corporation | Alkylsulfonamido or perfluoroalkylsulfonamido benzenesulfonamides |
| WO1995024186A1 (fr) * | 1994-03-11 | 1995-09-14 | Pharmacopeia, Inc. | Derives de sulfonamide et leurs utilisations |
| JP2001162950A (ja) * | 1999-12-13 | 2001-06-19 | Fuji Photo Film Co Ltd | 感熱記録材料 |
| JP4139712B2 (ja) * | 2002-03-14 | 2008-08-27 | ライオン株式会社 | 漂白活性化剤及び漂白剤組成物 |
| US7922702B2 (en) * | 2004-07-02 | 2011-04-12 | Qlt Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
| SE0401969D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Piperidine derivatives |
| WO2008071421A1 (fr) * | 2006-12-15 | 2008-06-19 | Nicox S.A. | Esters de l'acide nitrique des inhibiteurs d'anhydrase carbonique |
-
2007
- 2007-04-20 SK SK54-2007A patent/SK542007A3/sk unknown
-
2008
- 2008-03-11 TW TW097108546A patent/TWI392492B/zh not_active IP Right Cessation
- 2008-04-04 AR ARP080101430A patent/AR065966A1/es unknown
- 2008-04-17 UY UY31028A patent/UY31028A1/es not_active Application Discontinuation
- 2008-04-17 JO JOP/2008/0180A patent/JO3206B1/ar active
- 2008-04-18 PT PT87419792T patent/PT2142499E/pt unknown
- 2008-04-18 PE PE2008000680A patent/PE20090807A1/es not_active Application Discontinuation
- 2008-04-18 HR HRP20141246AT patent/HRP20141246T1/hr unknown
- 2008-04-18 RU RU2009134079/04A patent/RU2474574C2/ru not_active IP Right Cessation
- 2008-04-18 HU HUE08741979A patent/HUE024552T2/hu unknown
- 2008-04-18 SI SI200831379T patent/SI2142499T1/sl unknown
- 2008-04-18 DK DK08741979.2T patent/DK2142499T3/en active
- 2008-04-18 MX MX2009010528A patent/MX2009010528A/es active IP Right Grant
- 2008-04-18 JP JP2010504023A patent/JP5492764B2/ja not_active Expired - Fee Related
- 2008-04-18 BR BRPI0809728A patent/BRPI0809728A2/pt not_active IP Right Cessation
- 2008-04-18 UA UAA200910016A patent/UA99279C2/ru unknown
- 2008-04-18 ES ES08741979.2T patent/ES2528284T3/es active Active
- 2008-04-18 PL PL08741979T patent/PL2142499T3/pl unknown
- 2008-04-18 CA CA2684591A patent/CA2684591C/fr not_active Expired - Fee Related
- 2008-04-18 WO PCT/SK2008/050005 patent/WO2008130332A1/fr not_active Ceased
- 2008-04-18 CL CL2008001109A patent/CL2008001109A1/es unknown
- 2008-04-18 EP EP08741979.2A patent/EP2142499B1/fr active Active
- 2008-04-18 NZ NZ581302A patent/NZ581302A/en not_active IP Right Cessation
- 2008-04-18 CN CN200880012806A patent/CN101663267A/zh active Pending
- 2008-04-18 AU AU2008241590A patent/AU2008241590B2/en not_active Ceased
- 2008-04-19 SA SA08290238A patent/SA08290238B1/ar unknown
- 2008-04-20 US US12/596,820 patent/US8193184B2/en not_active Expired - Fee Related
-
2009
- 2009-09-10 ZA ZA200906305A patent/ZA200906305B/xx unknown
- 2009-09-15 IL IL200952A patent/IL200952A0/en not_active IP Right Cessation
- 2009-10-13 TN TNP2009000421A patent/TN2009000421A1/fr unknown
- 2009-11-05 MA MA32329A patent/MA31364B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhu et al. | A catalyst-free and additive-free method for the synthesis of benzothiazolethiones from o-iodoanilines, DMSO and potassium sulfide | |
| PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
| MA31319B1 (fr) | Dérivés de sulfonylamides destines au traitement d'une croissance cellulaire anormale | |
| TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| TR200101478T2 (tr) | Organik bileşikler. | |
| BRPI0212775B8 (pt) | composto de 1,2,4-triazol e medicamento | |
| MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
| NO20080157L (no) | Fremgangsmate for syntese av organiske forbindelser | |
| FR2854633A1 (fr) | Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| HRP20090474T1 (hr) | Postupak i intermedijeri za sintezu kaspofungina | |
| EA200601295A1 (ru) | Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета | |
| ATE482933T1 (de) | Sulfopyrrolderivate | |
| EA200970555A1 (ru) | Трициклическое соединение и его медицинское применение | |
| DK1694641T3 (da) | Prostaglandinsyntese | |
| MA31364B1 (fr) | Sulfamides substitués, leur procédé de préparation, composition pharmaceutique en contenant et leur utilisation | |
| BRPI0416678A (pt) | pirazolpirimidinas | |
| MY143665A (en) | Method of producing aminophenol compounds. | |
| DE60210719D1 (de) | Verbindung enthaltend einen heterozyklischen Ring sowie eine Schmiermittelmischung enthaltend diese | |
| EA200401077A1 (ru) | 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b | |
| Du et al. | Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virus | |
| ATE297900T1 (de) | Anilidverbindungen und medikamente, die diese enthalten | |
| MA29534B1 (fr) | Agents de couplage de benzenephosphonate organometallique | |
| UA90290C2 (ru) | Производные спирокеталов и их применение в качестве лекарственного средства против диабета |